Back Pain & Radiculopathy

📋 Key Information Summary

📋

Back pain is the leading cause of disability in Australia, affecting ~4 million Australians annually and costing over $4.8 billion per year (AIHW 2023). Most episodes are mechanical and self-limiting.
Red flags must be screened at first presentation: cauda equina syndrome (saddle anaesthesia, urinary retention, bilateral sciatica) requires emergent MRI and surgical review within 24–48 hours.
Suspect spinal infection in immunocompromised patients, IVDU, or those with fever + back pain + elevated CRP/ESR. Blood cultures and urgent MRI with gadolinium are first-line.
Spinal malignancy should be considered in patients >50 years with unexplained weight loss, night pain, prior cancer history, or failure to improve after 4–6 weeks.
Vertebral fracture is likely with minor trauma in the elderly, corticosteroid use, or osteoporosis. Plain X-ray is first-line; CT or MRI if equivocal.
Inflammatory back pain (morning stiffness >30 min, improves with activity, onset <40 years, night waking) warrants HLA-B27, ESR/CRP, and sacroiliac joint imaging — refer rheumatology.
Mechanical low back pain: reassure patients, encourage continued activity (avoid bed rest), first-line analgesia with paracetamol ± NSAIDs. Routine imaging is NOT recommended unless red flags or radiculopathy present.
Imaging indications: red flags, progressive neurological deficit, radiculopathy not improving after 6 weeks, or pre-procedural planning. MRI is preferred for soft-tissue evaluation.
Radiculopathy presents with dermatomal pain, sensory loss, motor weakness, and diminished reflexes. L5 and S1 nerve roots are most commonly affected.
Conservative management for radiculopathy (education, activity modification, physiotherapy, short-course oral corticosteroids or gabapentinoids) resolves ~90% of cases within 6–12 weeks.
Lumbar spinal stenosis causes neurogenic claudication: bilateral buttock/leg pain worsened by extension and walking, relieved by sitting or flexion. MRI confirms diagnosis.
Refer for interventional or surgical assessment when conservative care fails after 6–12 weeks, there is progressive neurological deficit, cauda equina syndrome, or severe functional limitation.
Aboriginal and Torres Strait Islander Australians experience higher rates of back pain disability, delayed presentation, reduced access to specialist and allied health services, and poorer pain management outcomes.

Introduction & Australian Epidemiology

Back pain, encompassing low back pain, thoracic pain, and neck pain, is the leading cause of years lived with disability (YLD) in Australia and globally. Radiculopathy — nerve root compression causing radiating limb pain, sensory disturbance, and/or motor weakness — is one of the most common complications of degenerative spinal disease and a frequent reason for specialist referral.

In Australia, the burden is substantial:

Prevalence: Approximately 4.0 million Australians (16% of the population) report back problems as a chronic condition (AIHW 2023). Lifetime prevalence of low back pain is estimated at 80%.
Health system impact: Back problems are the 4th leading cause of total disease burden and account for ~$4.8 billion in direct healthcare costs annually, including GP visits, imaging, pharmaceuticals, allied health, and surgery.
GPs manage ~85% of back pain presentations in primary care. Lumbar radiculopathy accounts for approximately 5–10% of all low back pain presentations.
Spinal surgery rates in Australia have increased by ~50% over the past two decades, driven by spinal fusion and decompression procedures. Evidence supports surgery only for specific indications (e.g., cauda equina syndrome, progressive deficit, confirmed stenosis with refractory symptoms).
Imaging overuse: Despite guideline recommendations, approximately 25–30% of patients with simple low back pain in Australian general practice receive imaging within 6 weeks of presentation — a key target for quality improvement under the ACSQHC Lumbar Spinal Conditions Clinical Care Standard.

⚠️

Clinical keypoint: Over 90% of low back pain presentations are "non-specific" (mechanical) with no identifiable serious pathology. The clinical priority is to rule out red flags, then manage conservatively with reassurance, activity, and simple analgesia — not to chase a structural diagnosis.

This guideline covers the systematic assessment of back pain to identify serious pathology ("red flags"), evidence-based management of mechanical low back pain and radiculopathy, and pathways for specialist referral in the Australian context.

Red Flags in Back Pain

Red flag screening is the single most important step in the initial assessment of back pain. The purpose is to identify the small proportion of patients (<2%) with serious underlying pathology — cauda equina syndrome, spinal infection, malignancy, fracture, or inflammatory spondyloarthropathy — requiring urgent investigation and management.

Cauda Equina Syndrome (CES)

CES is a surgical emergency caused by compression of the cauda equina nerve roots, most commonly by a massive lumbar disc herniation, tumour, epidural abscess, or traumatic fracture.

🚨

Emergency — Cauda Equina Syndrome: Suspect CES in any patient with back pain plus: (1) new urinary retention or incontinence, (2) saddle (perineal/genital) sensory loss, (3) bilateral sciatica, (4) progressive bilateral lower limb weakness, or (5) loss of anal sphincter tone. Arrange urgent MRI and spinal surgical consultation within 24–48 hours. Delayed decompression (>48 hours) worsens functional outcomes.

Feature	Key Findings	Immediate Action
Urinary symptoms	Retention, overflow incontinence, loss of sensation during voiding	Post-void bladder scan; if residual >200 mL → urgent referral
Saddle anaesthesia	Reduced sensation over perineum, buttocks, inner thighs, genitalia	Document dermatomal pattern; urgent MRI
Bilateral sciatica	Pain radiating below knees bilaterally — more concerning than unilateral	Urgent MRI lumbar spine
Motor deficit	Bilateral foot drop, bilateral ankle/knee weakness, wide-based gait	Urgent MRI; spinal surgical review
Anal tone	Reduced or absent anal sphincter contraction on digital rectal examination	Urgent MRI and surgical consultation

Spinal Infection

Spinal infections include vertebral osteomyelitis, discitis, and epidural abscess. Staphylococcus aureus (including MRSA in healthcare-associated and some community settings) is the most common causative organism. Gram-negative bacilli and Mycobacterium tuberculosis should be considered in immunocompromised, migrant, and Indigenous populations.

⚠️

Suspect spinal infection if: fever or rigors + back pain, IVDU, recent spinal procedure, immunosuppression (diabetes, chemotherapy, corticosteroids, HIV), elevated inflammatory markers (CRP >50 mg/L, ESR >40 mm/hr), or failure to improve with standard management after 2–4 weeks. Perform blood cultures (×2 sets) and request urgent MRI with gadolinium.

Spinal Malignancy

Metastatic disease to the spine is far more common than primary spinal tumours. The most common primaries include lung, breast, prostate, renal, and thyroid cancers, as well as multiple myeloma. Approximately 5–10% of cancer patients develop spinal metastases.

Red Flag for Malignancy	Significance
Age >50 years with first episode of back pain	Higher malignancy prevalence in this age group
Unexplained weight loss (>5% body weight in 3 months)	Suggests systemic disease
Night pain / pain at rest that wakes from sleep	Inflammatory or neoplastic pain pattern
Previous history of cancer	High risk of osseous metastases
Failure to improve after 4–6 weeks of appropriate care	Warrants further investigation for occult pathology
Thoracic back pain in an older adult	Thoracic pain is less commonly mechanical; higher concern for malignancy or fracture

Vertebral Fracture

Vertebral fractures may be traumatic or atraumatic (osteoporotic). Risk factors include age >65, osteoporosis (T-score ≤ −2.5), prolonged corticosteroid use (>3 months of ≥5 mg prednisolone daily), minimal trauma (fall from standing height), and history of fragility fracture.

Clinical suspicion: focal bony tenderness, age >65, recent fall or trauma, corticosteroid use, known osteoporosis
Initial imaging: plain X-ray (lateral and AP views) — sensitivity ~80% for osteoporotic fractures
If X-ray equivocal: CT for bony detail or MRI (STIR sequences) to detect occult fracture and bone marrow oedema
Assess for osteoporosis: request DEXA scan if not recently performed; consider initiating anti-resorptive therapy

Inflammatory Back Pain (Axial Spondyloarthropathy)

Axial spondyloarthropathy (including ankylosing spondylitis and non-radiographic axial SpA) affects predominantly young adults (onset <45 years) and is frequently diagnosed 5–10 years after symptom onset due to delayed recognition. Early identification allows initiation of disease-modifying therapy.

Feature Suggesting Inflammatory Back Pain	Detail
Age of onset <40 years	Most patients present between 20–35 years
Insidious onset	Gradual, not linked to specific injury
Duration >3 months	Persistent rather than episodic
Morning stiffness >30 minutes	Improves with movement and warm showers
Improves with exercise, worsens with rest	Opposite pattern to mechanical back pain
Night pain — waking in second half of night	Characteristic of inflammatory pain
Alternating buttock pain	Sacroiliitis pattern

Investigations for suspected inflammatory back pain: ESR, CRP, HLA-B27, and plain X-ray of pelvis (AP) with sacroiliac joint views. MRI of the sacroiliac joints (STIR and T1 sequences) is the preferred first-line imaging if available, as it can detect active sacroiliitis before radiographic changes develop. Refer to rheumatology for confirmation and management.

Summary of Red Flags by Category

Category	Key Red Flag Features	First Investigation	Urgency
Cauda equina	Saddle anaesthesia, urinary retention, bilateral sciatica, reduced anal tone	Urgent MRI	Emergent — within 24 h
Infection	Fever, IVDU, immunosuppression, raised CRP/ESR	Blood cultures, CRP/ESR, MRI with gad	Urgent — within 24–48 h
Malignancy	Age >50, weight loss, night pain, cancer history	MRI, FBC, ESR/CRP, calcium, PSA (if prostate suspected)	Urgent — within 2 weeks
Fracture	Trauma, age >65, corticosteroid use, osteoporosis	Plain X-ray; CT if equivocal	Prompt — within 48 h
Inflammatory SpA	Onset <40, morning stiffness >30 min, improves with activity	ESR/CRP, HLA-B27, SIJ MRI	Non-urgent — rheumatology referral

Mechanical Low Back Pain

Mechanical (non-specific) low back pain accounts for over 90% of presentations. It arises from the lumbar intervertebral discs, facet joints, sacroiliac joints, ligaments, and paraspinal muscles. The exact anatomical source of pain can rarely be identified, and this does not impede effective management.

Clinical Assessment

History: site, onset, duration, radiation, aggravating/relieving factors, functional impact, psychosocial yellow flags (fear-avoidance beliefs, catastrophising, workplace dissatisfaction, compensation)
Examination: lumbar range of motion, straight leg raise (SLR), neurological examination of lower limbs (L4–S1 myotomes, dermatomes, reflexes), gait assessment
Red flag screen: systematically exclude cauda equina, infection, malignancy, fracture, inflammatory pain (see Red Flags section above)

Initial Management Principles

✅

Reassurance and education are the most effective interventions. Advise patients: (1) back pain is common and almost always resolves, (2) the back is strong and designed for movement, (3) most scans show age-related changes that are NOT the cause of pain, and (4) staying active is the single most important factor for recovery.

1

Reassure & Educate

Explain the benign nature; address fears and misconceptions; set expectations for recovery (most resolve within 6 weeks).

2

Stay Active

Advise against bed rest. Encourage continuation of normal activities within pain tolerance. Walking, swimming, and gentle stretching are beneficial.

3

Simple Analgesia

Paracetamol regular dosing; NSAIDs if no contraindications. Avoid opioids. Short-course muscle relaxants only if significant spasm.

4

Physiotherapy / Exercise

Referral to physiotherapist for structured exercise programme, manual therapy, and graded activity. Particularly important if not improving after 2 weeks.

5

Address Yellow Flags

Screen for psychosocial barriers. Cognitive-behavioural approaches, workplace liaison, and early return-to-work planning improve outcomes.

Activity Advice

Do NOT prescribe bed rest — bed rest beyond 24–48 hours worsens outcomes and increases chronicity
Encourage gentle, graduated return to normal daily activities and work (even with some discomfort)
Walking programme: 20–30 minutes daily, progressing as tolerated
Avoid prolonged sitting (>30 minutes without movement breaks)
Heat therapy (heat packs, warm showers) provides modest short-term symptom relief

Simple Analgesics

💊

Paracetamol

Panadol®, Panamax® · Non-opioid analgesic

Adult dose 500–1000 mg PO every 4–6 hours (max 4 g/day)

Paediatric dose 15 mg/kg PO every 4–6 hours (max 60 mg/kg/day)

Duration As needed; regular dosing preferred in acute phase (1–2 weeks)

Renal adjustment Reduce max dose in severe hepatic impairment (≤2 g/day); dose interval increase in severe renal impairment

PBS status ✔ PBS General Benefit

💊

Ibuprofen

Nurofen®, Brufen® · NSAID

Adult dose 200–400 mg PO every 6–8 hours (max 1200 mg/day OTC; 2400 mg/day Rx)

Paediatric dose 5–10 mg/kg PO every 6–8 hours (max 30 mg/kg/day)

Duration Shortest effective course; typically 5–14 days. Use with PPI cover if prolonged.

Renal adjustment Avoid if eGFR <30 mL/min; use with caution if eGFR 30–60. Monitor renal function if prolonged use.

PBS status ✔ PBS General Benefit

💊

Naproxen

Naprosyn®, Inza® · NSAID

Adult dose 250–500 mg PO every 12 hours (max 1000 mg/day)

Duration 5–14 days; longer courses require GI protection

Renal adjustment Avoid if eGFR <30 mL/min

PBS status ✔ PBS General Benefit

⚠️

NSAID safety reminders: Use the lowest effective dose for the shortest duration. Avoid in significant renal impairment (eGFR <30), active GI bleeding, severe heart failure, and late pregnancy. Add a PPI (e.g., omeprazole 20 mg daily) for patients with GI risk factors. NSAIDs are associated with increased cardiovascular risk — exercise caution in patients with ischaemic heart disease.

Short-Term Muscle Relaxants (for significant muscle spasm)

💊

Diazepam

Diazemuls®, Valium® · Benzodiazepine

Adult dose 2–5 mg PO every 8 hours for acute spasm; max 5 days

Duration ≤5 days only — risk of dependence with prolonged use

Renal adjustment No adjustment required

PBS status ✔ PBS General Benefit

🚨

Avoid opioids for acute non-specific low back pain. Opioids do not provide clinically meaningful benefit over simple analgesia but carry significant risks including dependence, respiratory depression, and increased chronicity. Reserve opioids for severe pain unresponsive to other measures, short duration (≤3 days), and with clear review plan. Do not initiate opioids for chronic non-specific back pain.

Imaging Indications

Routine imaging for acute low back pain (presenting within 6 weeks, no red flags) is not recommended and may cause harm through label anxiety, unnecessary procedures, and radiation exposure.

Imaging Indication	Preferred Modality	Notes
Suspected fracture	Plain X-ray (AP + lateral)	CT if X-ray equivocal; MRI for occult fractures
Red flags for infection or malignancy	MRI with gadolinium (± contrast)	Highest sensitivity for soft tissue, marrow infiltration, epidural collections
Cauda equina syndrome	Urgent MRI	MRI of choice; CT myelography if MRI unavailable
Radiculopathy not improving after 6 weeks	MRI lumbar spine	Confirms disc herniation, nerve root compression, stenosis
Pre-procedural planning (injection/surgery)	MRI lumbar spine	Required before any interventional procedure
Suspected inflammatory sacroiliitis	MRI sacroiliac joints (STIR + T1)	Detects active inflammation before radiographic change

Common incidental findings on MRI that are NOT necessarily the cause of pain (present in asymptomatic individuals): disc bulges (30–60% of asymptomatic adults), degenerative disc changes (60% over age 40), facet joint arthrosis, Schmorl's nodes, and mild foraminal stenosis. These findings should be interpreted in clinical context and not used to label patients with frightening diagnoses.

Radiculopathy & Lumbar Spinal Stenosis

Lumbar Radiculopathy

Lumbar radiculopathy is caused by compression, inflammation, or ischaemia of a spinal nerve root, most commonly by a disc herniation at L4–L5 or L5–S1. It affects the L5 and S1 nerve roots in approximately 90% of cases. The annual incidence is approximately 3–5% in adults aged 25–55 years.

Clinical Features by Nerve Root

Nerve Root	Pain Distribution	Motor Deficit	Sensory Loss	Reflex
L3	Anterior thigh to knee	Quadriceps weakness (difficulty climbing stairs)	Anterior thigh / medial knee	Knee jerk diminished
L4	Anterolateral thigh to medial malleolus	Tibialis anterior weakness (foot dorsiflexion)	Medial calf / medial malleolus	Knee jerk diminished
L5	Lateral leg, dorsum of foot, great toe	Extensor hallucis longus / tibialis anterior (foot drop)	Dorsum of foot, first web space	Usually normal
S1	Posterior leg, lateral foot, sole	Gastrocnemius/soleus (difficulty walking on toes, impaired push-off)	Lateral foot, sole, 4th–5th toes	Ankle jerk diminished or absent

Key clinical tests:

Straight leg raise (SLR) test: positive when leg elevation to 30–70° reproduces radicular pain below the knee. Sensitivity ~90%, specificity ~30% for L4–S1 disc herniation.
Crossed SLR: positive when raising the unaffected leg reproduces symptoms in the affected leg. Specificity ~90% — highly suggestive of disc herniation.
Femoral nerve stretch test (reverse SLR): positive when prone knee flexion reproduces anterior thigh pain — suggests upper lumbar radiculopathy (L2–L4).

Lumbar Spinal Stenosis

Lumbar spinal stenosis (LSS) is narrowing of the spinal canal, lateral recess, or neural foramina, most commonly due to degenerative changes (ligamentum flavum hypertrophy, facet joint arthrosis, disc bulging). It is the most common reason for spinal surgery in patients over 65 years.

💡

Neurogenic claudication is the hallmark of lumbar spinal stenosis: bilateral buttock and leg pain provoked by walking or standing (extension) and relieved by sitting or forward flexion (shopping cart sign). Unlike vascular claudication, symptoms are positional, distances are variable, and peripheral pulses are present.

Feature	Neurogenic Claudication (Stenosis)	Vascular Claudication (PAD)
Pain location	Buttock → thigh → leg (bilateral common)	Calf (usually unilateral initially)
Provocation	Walking, standing, lumbar extension	Walking (consistent distance)
Relief	Sitting, forward flexion, lying	Standing still
Walking distance	Variable; may be better uphill/worse downhill	Reproducible fixed distance
Peripheral pulses	Present and normal	Diminished or absent
ABPI	Normal (>0.9)	Reduced (<0.9)

Conservative Management of Radiculopathy & Stenosis

1

Education & Reassurance

~90% of disc-related radiculopathy improves within 6–12 weeks with conservative care. MRI findings often do not correlate with symptoms. Avoid catastrophising language.

2

Activity Modification

Maintain activity within tolerance. Avoid prolonged bed rest. Lumbar flexion exercises and cycling may benefit stenosis. Avoid heavy lifting and prolonged extension initially.

3

Pharmacotherapy

NSAIDs (first-line), short-course oral corticosteroids (taper), gabapentinoids for neuropathic pain. Avoid opioids.

4

Physiotherapy

McKenzie method, core stabilisation, nerve gliding exercises, graded walking programme. Referral within 2–4 weeks if not improving.

5

Re-assessment at 6 Weeks

If not improving, request MRI (if not done), consider gabapentinoid trial, refer for epidural corticosteroid injection or surgical opinion.

When to Order MRI

Radiculopathy with progressive or severe neurological deficit (foot drop, significant weakness)
Radiculopathy not improving after 6 weeks of conservative management
Suspected cauda equina syndrome (emergent — same-day MRI)
Suspected spinal infection or malignancy
Neurogenic claudication consistent with spinal stenosis — MRI confirms diagnosis and guides treatment planning
Pre-procedural planning for epidural injection or surgery

MRI availability in Australia: MRI lumbar spine is available on Medicare (MBS) for patients referred by a medical practitioner for clinically suspected radiculopathy or spinal stenosis meeting specific criteria. Bulk-billed MRI services are widely available in metropolitan areas but may be limited in rural and remote settings, where CT is the more accessible alternative.

Referral for Interventional Procedures

⚠️

Epidural corticosteroid injections (transforaminal or interlaminar) can provide short-to-medium-term pain relief (weeks to months) for radiculopathy and may facilitate physiotherapy engagement. They are NOT a definitive treatment for disc herniation and should not replace surgery when indicated. Evidence for long-term benefit (>12 months) is limited.

Procedure	Indication	Evidence	Access
Epidural corticosteroid injection (transforaminal)	Unilateral radiculopathy with confirmed disc herniation on MRI; conservative care failed 6+ weeks	Short-term relief (4–12 weeks); moderate evidence	Pain specialist, interventional radiologist, or spinal surgeon
Epidural corticosteroid injection (interlaminar/caudal)	Bilateral radiculopathy or spinal stenosis with neurogenic claudication	Short-term benefit; weaker evidence for stenosis than radiculopathy	Pain specialist or spinal surgeon
Facet joint injection / medial branch block	Suspected facet joint pain (axial pain, extension-provoked, no radiculopathy)	Diagnostic; may guide radiofrequency denervation	Pain specialist, interventional radiologist

Surgical Referral Indications

Absolute: cauda equina syndrome (emergent decompression); progressive motor deficit despite conservative care
Strong indication: radiculopathy with confirmed large disc herniation causing significant motor deficit (e.g., foot drop) — best outcomes with surgery within 6 months
Elective indication: neurogenic claudication from spinal stenosis with severe functional limitation not responding to 3–6 months of conservative management and/or epidural injections
Spinal surgery consultation (neurosurgery or orthopaedic spine) should be arranged when surgery is being considered. In Australia, public wait times can be 3–12 months; private referral may be faster.

Surgery for radiculopathy: Microdiscectomy is the most common surgical procedure. Evidence from the SPORT trial and subsequent studies shows that surgery provides faster relief of leg pain compared to conservative management, but differences narrow by 1–2 years. Most patients still recover with conservative management.

Surgery for spinal stenosis: Decompressive laminectomy is the standard procedure. The SPORT trial showed superior outcomes for surgery over conservative care at 2 and 4 years in patients with confirmed stenosis and persistent symptoms. Spinal fusion is reserved for cases with instability or spondylolisthesis.

Pathophysiology

Sources of Back Pain

The lumbar spine is a complex biomechanical structure. Pain may originate from multiple structures, and in most cases of non-specific back pain, the exact source cannot be identified with certainty.

Intervertebral disc: Annular tears, internal disc disruption, and degenerative disc disease. The nucleus pulposus is avascular and has poor healing capacity. Disc degeneration begins in the second decade of life.
Facet (zygapophyseal) joints: Arthrosis, synovitis, and capsular irritation. These joints are innervated by the medial branch of the dorsal ramus. Responsible for ~15–30% of chronic low back pain.
Sacroiliac joints: Dysfunction or inflammation. Accounts for ~15–25% of low back pain. Provocation tests (FABER, compression, distraction) aid diagnosis.
Paraspinal muscles and ligaments: Muscle strain, myofascial trigger points, and ligamentous sprain — common in acute presentations.
Spinal nerve roots: Compression or inflammation by disc herniation, osteophytes, or stenosis causes radiculopathy. Biochemical mediators (phospholipase A2, TNF-α, IL-1β, IL-6) released from herniated disc material cause chemical radiculitis independent of mechanical compression.

Disc Herniation & Radiculopathy Mechanism

Disc herniation occurs when nuclear material breaches the annulus fibrosus. The postero-lateral position is most common (where the annulus is thinnest), directing herniation toward the traversing nerve root within the spinal canal or the exiting nerve root within the foramen. The L4–L5 and L5–S1 levels account for ~95% of lumbar disc herniations due to the high biomechanical loads at these segments.

Stenosis Pathophysiology

Spinal stenosis is a progressive condition resulting from degenerative changes that narrow the spinal canal. The pathological cascade includes: (1) disc degeneration and bulging, (2) facet joint hypertrophy and osteophyte formation, (3) ligamentum flavum thickening and buckling, and (4) loss of disc height causing foraminal narrowing. Symptoms are related to posture-dependent compression of neural structures — extension narrows the canal by up to 15%, while flexion increases it.

Investigations

Investigations in back pain are guided by the clinical context — red flag screening, assessment of radiculopathy severity, and pre-procedural planning. Routine laboratory and imaging investigations are not indicated for simple mechanical low back pain.

Laboratory Investigations

Available

FBC, ESR, CRP

Screen for infection (elevated WCC, CRP >50, ESR >40) or malignancy (anaemia, leucoerythroblastic film). Request if red flags present.

Available

Blood cultures (×2 sets)

If spinal infection suspected — obtain before antibiotics. Positive in ~50–60% of vertebral osteomyelitis cases.

Available

HLA-B27

If inflammatory back pain / axial spondyloarthropathy suspected. Positive in ~90% of ankylosing spondylitis but also ~8% of general population — interpret with clinical context.

Available

Serum protein electrophoresis + free light chains

If multiple myeloma suspected (back pain + anaemia + renal impairment + hypercalcaemia in older adult).

Available

PSA (prostate-specific antigen)

If prostate metastasis suspected (male with back pain + known prostate cancer or suspicious features).

Available

Serum calcium, ALP, vitamin D

Assess for metabolic bone disease in patients with suspected osteoporotic fracture. Hypercalcaemia may suggest malignancy.

Imaging

First-line

Plain X-ray lumbar spine (AP + lateral)

First-line for suspected fracture. Limited sensitivity for soft tissue pathology. Available under MBS for red flag indications. Two views standard.

Available

CT lumbar spine

Superior bony detail. Useful for fracture characterisation, bony stenosis assessment, and when MRI is contraindicated. Available under MBS.

Gold standard

MRI lumbar spine (± gadolinium)

Gold standard for soft tissue — disc herniation, nerve root compression, stenosis, infection, and malignancy. Gadolinium contrast enhances detection of infection and tumour. Available on Medicare for specific clinical indications. Allow 1–3 week wait in public settings; same-day or next-day in private/emergency.

Available

MRI sacroiliac joints

Preferred first-line imaging for suspected axial spondyloarthropathy (STIR + T1 sequences). Detects active sacroiliitis (bone marrow oedema) before radiographic changes.

Specialist

CT myelography

Alternative to MRI when MRI is contraindicated (e.g., pacemaker, ferromagnetic implants). Requires lumbar puncture and intrathecal contrast.

Available

DEXA scan (bone densitometry)

Assess bone mineral density in patients with suspected osteoporotic fracture. Available under MBS for specific indications (age ≥70, fragility fracture, corticosteroid use).

Electrodiagnostic Studies

Specialist

Nerve conduction studies (NCS) / Electromyography (EMG)

Useful when diagnosis of radiculopathy is uncertain, to differentiate radiculopathy from peripheral neuropathy or plexopathy, and to assess severity of nerve injury. Not routinely required if MRI and clinical findings are concordant. Performed by neurologist or rehabilitation specialist.

Risk Stratification

Risk stratification for chronicity and poor outcome is essential to guide management intensity. The STarT Back Screening Tool (SBST) and assessment of "yellow flags" (psychosocial risk factors) are recommended in Australian guidelines.

STarT Back Screening Tool — Risk Categories

Low Risk

Low Risk of Poor Outcome

SBST total score 0–3. Few psychosocial prognostic indicators. High likelihood of spontaneous recovery.

Setting: GP — reassurance, self-management, activity advice, simple analgesia

Medium Risk

Medium Risk of Poor Outcome

SBST total score ≥4 with low psychosocial subscale. Moderate physical and psychosocial factors contributing.

Setting: GP + physiotherapy — structured exercise, manual therapy, address yellow flags

High Risk

High Risk of Poor Outcome

SBST psychosocial subscale ≥4. Dominated by psychosocial barriers: catastrophising, fear-avoidance, depression, work dissatisfaction, compensation.

Setting: Multidisciplinary — physiotherapy + psychology (CBT) + occupational therapy + pain medicine consideration

Yellow Flags — Psychosocial Risk Factors for Chronicity

Domain	Yellow Flag Indicators
Beliefs & attitudes	"My spine is damaged"; fear of movement; belief that pain equals harm; expectation that passive treatments are required
Emotional state	Depression, anxiety, irritability, catastrophising, low self-efficacy
Behavioural	Avoidance of activity, excessive rest, over-reliance on medication, withdrawal from social activities
Work-related	Job dissatisfaction, heavy physical demands, unsupportive employer, workplace conflict, pending workers' compensation claim
Social	Social isolation, low socioeconomic status, poor family support, compensation/litigation involvement

Patients with high yellow flag burden benefit most from multidisciplinary pain management programmes combining physical rehabilitation with cognitive-behavioural therapy. In Australia, these are available through public pain management clinics and some private providers, though wait times can be significant (3–12 months in public settings).

Pharmacological Management

Empirical Therapy — Acute Mechanical Low Back Pain

Acute mechanical LBP (first-line)

Paracetamol ± ibuprofen or naproxen

1–4 weeks

Encourage activity; avoid bed rest

Muscle spasm dominant

Diazepam 2–5 mg PO TDS PRN

≤5 days

Short course only; sedation risk

NSAID contraindicated

Paracetamol ± heat therapy

Ongoing

Consider topical NSAID for localised pain

Empirical Therapy — Acute Radiculopathy

💊

Prednisolone

Panafcortelone® · Oral corticosteroid

Adult dose 40–50 mg PO daily for 5 days, then taper over 5–7 days (total course ~10–14 days)

Indication Acute radiculopathy with significant neuropathic pain — short course may reduce nerve root inflammation

Renal adjustment No adjustment required

Caution Avoid in uncontrolled diabetes, active infection, peptic ulcer disease. Monitor BSL in diabetics.

PBS status ✔ PBS General Benefit

Directed Therapy — Neuropathic Pain Component

When radiculopathy persists beyond the acute phase (>4–6 weeks) or neuropathic pain is prominent (burning, shooting, electric, paraesthesiae), gabapentinoids or duloxetine should be considered. These medications target neuropathic pain mechanisms rather than nociceptive inflammation.

💊

Pregabalin

Lyrica® · Gabapentinoid / α2δ ligand

Adult dose Start 75 mg PO BD; titrate to 150–300 mg PO BD over 1–2 weeks

Max dose 600 mg/day in divided doses

Renal adjustment eGFR 30–60: max 150 mg BD; eGFR 15–30: max 75 mg BD; eGFR <15: 25 mg OD. Dialysis: supplemental dose post-HD.

Key adverse effects Dizziness, somnolence, peripheral oedema, weight gain. Avoid abrupt cessation (withdrawal). Taper over ≥1 week.

PBS status ⚑ Authority Required — neuropathic pain inadequately managed by simpler analgesics

💊

Gabapentin

Neurontin® · Gabapentinoid / α2δ ligand

Adult dose Start 300 mg PO OD (nightly); titrate to 300 mg TDS over 1–2 weeks. May increase to 600 mg TDS.

Max dose 3600 mg/day in divided doses

Renal adjustment eGFR 30–60: max 600 mg BD; eGFR 15–30: max 300 mg OD; eGFR <15: 300 mg every other day

PBS status ⚑ Authority Required — neuropathic pain

💊

Duloxetine

Cymbalta® · SNRI antidepressant

Adult dose Start 30 mg PO daily for 1 week, then increase to 60 mg PO daily

Indication Neuropathic pain (particularly with comorbid depression or anxiety); also effective in chronic musculoskeletal pain

Renal adjustment Avoid if eGFR <30 mL/min

Key adverse effects Nausea (transient), dry mouth, constipation, dizziness. Avoid with MAOIs. Risk of serotonin syndrome with other serotonergic agents.

PBS status ⚑ Authority Required — neuropathic pain or MDD

💊

Amitriptyline

Endep® · TCA antidepressant

Adult dose Start 10 mg PO nocte; titrate to 25–75 mg nocte

Indication Second-line neuropathic pain agent; useful when coexistent insomnia or depression

Renal adjustment No specific adjustment; use with caution in elderly

Key adverse effects Anticholinergic effects (dry mouth, constipation, urinary retention), sedation, weight gain, cardiac conduction abnormalities. Avoid in significant cardiac disease.

PBS status ✔ PBS General Benefit

💡

Paracetamol for low back pain — recent evidence update: The PACE trial (Williams et al., Lancet 2014) found that regular paracetamol did not significantly speed recovery from acute low back pain compared to placebo. However, paracetamol remains recommended as it may provide modest symptomatic relief and is safe. NSAIDs have stronger evidence for acute low back pain. The emphasis should remain on reassurance, activity, and avoiding bed rest.

Monitoring

Monitoring Plan

Initial presentation (Day 0)

Red flag screen; neurological examination (motor, sensory, reflexes, gait); pain and functional assessment (NRS 0–10, Oswestry Disability Index or Roland-Morris); psychosocial yellow flag screening; initiate management plan.

1–2 weeks

Telephone or in-person review: assess response to simple analgesia and activity advice; reinforce self-management; adjust pharmacotherapy if needed; initiate physiotherapy referral if not improving.

6 weeks

Reassess: if improving, continue current plan; if NOT improving → re-examine neurological status, consider MRI lumbar spine, consider gabapentinoid trial or corticosteroid taper, refer to physiotherapy or pain medicine if not already involved.

12 weeks

Persistent radiculopathy or stenosis: review MRI, consider epidural corticosteroid injection referral, surgical consultation if progressive deficit or severe functional limitation. Reassess for yellow flags and refer for multidisciplinary pain management if high-risk profile.

6 months

Chronic back pain management: focus on function (not pain elimination), graded exercise, psychological support, medication rationalisation, work/occupational rehabilitation. Consider referral to specialist pain service.

Neurological Monitoring in Radiculopathy

🚨

Urgent re-assessment (same-day MRI and surgical referral) if: new or worsening motor deficit (particularly foot drop or bilateral weakness), new bowel/bladder dysfunction, saddle anaesthesia, or bilateral neurological signs — these indicate possible cauda equina syndrome or progressive compression.

Motor function: test foot dorsiflexion (L4/L5), great toe extension (L5), plantarflexion (S1) at every visit
Reflexes: knee jerk (L4), ankle jerk (S1) — document changes
Sensory testing: light touch and pinprick in L4, L5, S1 dermatomes
Gait assessment: heel walk (L5), toe walk (S1), tandem gait

Pharmacological Monitoring

NSAIDs: renal function (eGFR) at baseline and after 2 weeks if prolonged use; blood pressure monitoring; GI risk assessment
Gabapentinoids: renal function before initiation and dose titration; assess for sedation, dizziness, peripheral oedema; monitor for misuse/dependence
Oral corticosteroids: blood glucose monitoring in diabetics (short course); monitor for GI side effects
Amitriptyline: ECG before initiation if cardiac history or age >50; monitor for anticholinergic effects

Special Populations

🤰 Pregnancy

Prevalence: 50–80% of pregnant women experience back pain; most common in 2nd and 3rd trimesters.

Red flags: same as non-pregnant; consider pre-eclampsia (epigastric pain), placental abruption, and pregnancy-related pelvic girdle pain as differential diagnoses.

Imaging: avoid X-ray and CT (ionising radiation); MRI without contrast is considered safe in all trimesters.

Pharmacotherapy:

Paracetamol: safe in pregnancy (first-line)

NSAIDs: avoid in 3rd trimester (premature ductus arteriosus closure, oligohydramnios); use with caution in 1st/2nd trimester

Gabapentinoids: limited data; generally avoided unless benefit outweighs risk

Physiotherapy, pelvic support belts, hydrotherapy, and acupuncture are recommended non-pharmacological approaches.

👶 Paediatrics

Back pain in children is uncommon and warrants thorough investigation — the prevalence of serious underlying pathology (infection, tumour, spondylolysis, Scheuermann's disease) is significantly higher than in adults.

Age <10 years: back pain is very unusual — strongly consider infection (discitis), tumour, or abuse.

Adolescents: spondylolysis (pars interarticularis defect, especially L5) is the most common cause in young athletes. Spondylolisthesis may develop.

Red flags in children: age <4, night pain, systemic symptoms (fever, weight loss), neurological signs, thoracic pain, history of malignancy.

Imaging: X-ray first-line; MRI for red flags; CT or SPECT scan for suspected spondylolysis.

Paracetamol (15 mg/kg QID) and ibuprofen (5–10 mg/kg TDS) are appropriate first-line analgesics. Gabapentinoids are not TGA-approved for paediatric neuropathic pain — specialist referral required.

👴 Elderly (>65 years)

Higher prevalence of: osteoporotic vertebral fracture, spinal stenosis, degenerative spondylolisthesis, and spinal metastases.

Vertebral compression fractures: may present with acute onset focal pain after minimal trauma. Up to 2/3 are asymptomatic and discovered incidentally. Treat with analgesia, bracing, and osteoporosis management (bisphosphonates, calcium, vitamin D).

Spinal stenosis is the most common indication for spinal surgery in the elderly. Conservative management is first-line; surgery reserved for refractory cases with good surgical fitness.

NSAIDs: use with extreme caution — increased GI bleeding risk, renal impairment, cardiovascular risk, and drug interactions. Prefer short-course paracetamol ± topical NSAID.

Gabapentinoids: start at lower doses (pregabalin 25–50 mg BD; gabapentin 100–200 mg nocte) due to increased sensitivity to CNS side effects (sedation, dizziness, falls risk).

Falls risk assessment is essential in elderly patients with back pain on gabapentinoids, opioids, or muscle relaxants.

🫘 Renal Impairment

NSAIDs: contraindicated if eGFR <30; use lowest dose for shortest time if eGFR 30–60. Monitor renal function.

Paracetamol: preferred analgesic; no adjustment needed for renal impairment alone (adjust dose for concurrent hepatic impairment).

Pregabalin: dose reduction mandatory (see pharmacological management section).

Gabapentin: significant dose reduction required; accumulates in renal failure.

Duloxetine: avoid if eGFR <30.

MRI contrast (gadolinium): use with caution if eGFR <30 due to risk of nephrogenic systemic fibrosis. Use lowest dose; avoid gadodiamide (Omniscan®).

🫁 Hepatic Impairment

Paracetamol: reduce maximum dose to ≤2 g/day in significant hepatic impairment (Child-Pugh B or C).

NSAIDs: avoid in severe hepatic impairment; use with caution in mild-moderate impairment.

Duloxetine: contraindicated in hepatic impairment (hepatotoxicity risk).

Amitriptyline: use with caution; hepatically metabolised. Start low, titrate slowly.

Oral corticosteroids: no specific adjustment, but monitor for hepatotoxicity with prolonged courses.

🛡️ Immunocompromised

High index of suspicion for spinal infection: vertebral osteomyelitis, discitis, and epidural abscess are more common in immunocompromised patients (diabetes, HIV, chemotherapy, biologics, chronic corticosteroids, organ transplant).

Atypical organisms: consider TB (especially in migrants from endemic areas and Indigenous Australians in some regions), fungal infections (aspergillus, candida in IVDU), and Gram-negative bacilli.

Diagnostic approach: blood cultures (×2 sets) BEFORE antibiotics → urgent MRI with gadolinium → CT-guided biopsy if organism uncertain.

Empirical antibiotics: consult infectious disease. Typical empirical regimen: IV flucloxacillin 2 g QID + oral rifampicin 300 mg BD (for staphylococcal coverage including some MRSA); adjust per culture and sensitivities.

Duration: typically 6 weeks of IV/oral antibiotics for vertebral osteomyelitis. Infectious disease specialist co-management is essential.

Aboriginal and Torres Strait Islander Health Considerations

Aboriginal and Torres Strait Islander Health

Back pain is one of the most prevalent chronic conditions among Aboriginal and Torres Strait Islander Australians, contributing significantly to disability and reduced quality of life. The AIHW reports that musculoskeletal conditions (including back pain) are the second leading cause of disease burden for Indigenous Australians. Important considerations include:

Higher disease burden

Aboriginal and Torres Strait Islander Australians experience back pain at 1.4 times the rate of non-Indigenous Australians, with higher rates of disability and functional limitation. Onset occurs at younger ages and severity is greater, reflecting cumulative socioeconomic disadvantage, higher rates of physical labour, trauma, and comorbidity.

Delayed presentation

Cultural factors, previous negative healthcare experiences, shame, and geographic isolation contribute to delayed presentation. By the time many Indigenous patients present with back pain, they may have significant functional disability or established chronic pain. Early engagement and culturally safe assessment are critical.

Spinal infection — TB and community-acquired MRSA

Tuberculous spondylitis (Pott's disease) remains more prevalent in remote Indigenous communities than in the general Australian population. Community-acquired MRSA (CA-MRSA), particularly the Southwest Pacific clone, is endemic in many remote communities and should be considered in any suspected spinal infection. Empirical antibiotic regimens should include MRSA cover (e.g., vancomycin or trimethoprim-sulfamethoxazole) pending culture results.

Access to imaging and specialist services

MRI and CT are unavailable in most remote communities. Patients may require aeromedical retrieval (RFDS) for urgent imaging. Telehealth consultations with spinal surgeons and pain medicine specialists can facilitate assessment and reduce unnecessary patient transfers. Plain X-ray is available in most Aboriginal Community Controlled Health Services (ACCHS).

Access to allied health

Physiotherapy, exercise physiology, and psychology services are limited in remote areas. Visiting allied health professionals, Aboriginal health workers trained in musculoskeletal assessment, and telehealth-delivered physiotherapy programmes are essential. The Closing the Gap PBS co-payment improves medication access.

Pharmacological considerations

Ensure medications are accessible through remote area health services and ACCHS. The Closing the Gap PBS co-payment provides free or reduced-cost PBS medicines for eligible Indigenous patients. Simplify regimens (once- or twice-daily dosing) to improve adherence. Avoid NSAIDs in communities where renal disease prevalence is high (e.g., CKD rates 3–5× higher in Indigenous Australians).

Cultural safety

Use culturally safe communication approaches. Acknowledge the impact of intergenerational trauma and social determinants of health. Aboriginal health workers and liaison officers should be involved in care planning. Concepts of pain and disability may differ; avoid imposing Western biomedical models without culturally appropriate framing. Men's and women's business considerations may affect examination and treatment preferences.

Inflammatory back pain

Axial spondyloarthropathy prevalence in Indigenous Australians is not well studied but may be higher due to elevated HLA-B27 prevalence in some communities. HLA-B27 testing and rheumatology referral should be considered for young Indigenous patients with chronic back pain and inflammatory features.

📚 References

1. Australian Commission on Safety and Quality in Health Care (ACSQHC). Lumbar Spinal Conditions Clinical Care Standard. Sydney: ACSQHC; 2023.
2. National Institute for Health and Care Excellence (NICE). Low back pain and sciatica in over 16s: assessment and management. NICE guideline [NG59]. London: NICE; 2016 (updated 2020).
3. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747.
4. Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368–2383.
5. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–491.
6. Traeger AC, Henschke N, Hübscher M, et al. Estimating the risk of chronic pain: development and validation of a prognostic model (PICKUP) for patients with acute low back pain. PLoS Med. 2016;13(5):e1002019.
7. Hill JC, Whitehurst DG, Lewis M, et al. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet. 2011;378(9802):1560–1571.
8. Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA. 2006;296(20):2441–2450.
9. Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical versus nonoperative treatment for lumbar spinal stenosis: four-year results of the Spine Patient Outcomes Research Trial (SPORT). Spine. 2010;35(14):1329–1338.
10. Australian Institute of Health and Welfare (AIHW). Back problems. AIHW; 2023. Available from: https://www.aihw.gov.au/reports/chronic-musculoskeletal-conditions/back-problems
11. Royal Australian College of General Practitioners (RACGP). Guideline for the management of knee, hip and osteoarthritis. Melbourne: RACGP; 2018 (with musculoskeletal pain sections).
12. Stynes S, Konstantinou K, Ogollah R, et al. Clinical diagnostic model for sciatica developed in primary care patients with low back-related leg pain. PLoS One. 2018;13(4):e0191682.
13. Chou R, Deyo R, Friedly J, et al. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):480–492.
14. Lin CWC, Verwoerd AJH, Mahnke AN, et al. How is radiating leg pain defined in clinical trials? A systematic review. Eur Spine J. 2020;29(3):466–478.
15. RHDAustralia (Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine — Northern Territory Chapter). NT Antimicrobial Treatment Guidelines — Spinal Infections. Darwin: RHDAustralia; 2023.